Clinical Software in Maryland

Maxim Biomedical is a vertically integrated in vitro diagnostics (IVD) development and manufacturing company with over 20 years of experience serving Fortune 100 companies and U.S. government agencies including the DoD, CDC, and NIH. The company provides end-to-end diagnostic solutions spanning assay development, product engineering, clinical and regulatory strategy, and full-scale manufacturing and fulfillment. Capabilities include antibody screening and conjugation, custom reagent and buffer formulation, lateral flow and ELISA immunoassay development, prototype and pilot-scale production, scalable manufacturing, reagent formulation and dispensing, device assembly and packaging, and in-process and final quality control testing. The company operates an FDA-registered, ISO 13485:2016-certified facility in environmentally controlled cleanrooms (ISO 5/7/8), with biochemistry and dry rooms. Manufacturing specialties include lateral flow, ELISA, and custom immunoassays with branded and private label solutions for retail, clinical, and government channels. Notable achievements include development and manufacturing of the ClearDetect® COVID-19 Antigen Home Test for the NIH RADx initiative and DoD, delivering 22+ million tests to the U.S. government, and a 15+ year partnership supporting Class III, BLA-regulated diagnostic products. The company serves as a contract development and manufacturing organization (CDMO) for diagnostics, supporting partners from early-stage concept through commercialization and sustained production.

Welldoc is a digital health platform company specializing in AI-driven chronic disease management, with a focus on diabetes, hypertension, heart failure, obesity, and behavioral health. Founded in 2005 by an endocrinologist, Welldoc delivers clinically-validated, evidence-based solutions that integrate personalized, real-time insights into patient workflows. The flagship product, BlueStar® (FDA-cleared prescription digital therapeutic), provides automated patient coaching and real-time guidance for adults with type 2 diabetes. Welldoc's platform enables "care anywhere" delivery models for health plans, healthcare systems, and employers, integrating disparate health data into actionable clinical insights across the cardiometabolic spectrum. The company collaborates with major partners including Abbott, CVS Health, Eli Lilly, Dexcom, and others, leveraging data science and behavioral algorithms to improve medication adherence, lifestyle change, and self-management outcomes.

Eitan Medical develops and markets infusion pump systems and digital health solutions for drug delivery across hospital, home care, emergency medical services, and infusion center settings. Primary product lines include Sapphire™ (multi-therapy infusion pump for hospitals, home care, and EMS) and Avoset™ (connected infusion pump with web-based programming and minimal setup steps). Eitan Insights™ is a cloud-based software platform providing remote treatment visibility, adherence tracking, and care analytics. The company serves hospitals, government healthcare (US Military), home care therapy providers, emergency medical services, infusion centers, and pharmaceutical partners. Applications include epidural infusion, total parenteral nutrition (TPN), pain management (PCA, PCEA, PIEB), and general IV therapy. With 15 years of operational experience, presence in 39+ countries, and 25 million liters infused globally, Eitan Medical positions itself as a provider of reliable, accurate, and user-friendly infusion solutions designed with safety and patient independence in mind. The company operates a global distribution and support network. Regulatory status and specific certifications (FDA 510(k), ISO 13485, CE marking) are not explicitly stated in the fetched content but are typical for Class II/III infusion pump devices.

Mansbach Health Tools LLC develops and markets the BCAT® (Brain Cognitive Assessment Tool), a Class II FDA-registered medical device (510(k) registration 3035111095) designed as a computerized cognitive assessment aid. The BCAT® system evaluates cognitive function through a battery of cognitive tasks and provides interpretive guidance to support clinical decision-making in cognitive status evaluation. The platform is not intended as a stand-alone diagnostic device and must be administered by qualified health professionals. The company offers an integrated cognitive ecosystem comprising four primary components: the BCAT® Test System (core assessment platform), BCAT® Interventions (targeted cognitive support tools), BCAT® Programs (structured implementation modules), and the ENRICH® Brain Health Program (broader cognitive wellness initiative). Market segments served include skilled nursing facilities, senior living communities, home care providers, and acute rehabilitation hospitals. The BCAT® system addresses the growing clinical need for effective, reliable cognitive decline assessment tools in dementia care and memory loss management. Product offerings include provider licensing, patient/family educational resources (such as the Working Memory Exercise Book), and clinical decision-support tools. The ENRICH® Calculator provides risk stratification and intervention planning. The platform targets healthcare providers managing cognitive decline, individuals concerned about memory loss, and families and caregivers seeking cognitive health resources. Regulatory compliance with FDA Class II medical device requirements is established.

Human BioSciences, Inc. (HBS) is an FDA-regulated biotechnology manufacturer specializing in proprietary collagen-based wound care products. Founded in 1996 and headquartered in Gaithersburg, Maryland, HBS develops, manufactures, and distributes advanced wound healing solutions utilizing its proprietary Kollagen™ technology—100% native, non-hydrolyzed Type I bovine collagen engineered to support all four phases of wound healing. The company's core product portfolio includes SkinTemp® II collagen dressings, Medifil® II collagen particles, and Collatek® collagen gel, indicated for burns, diabetic ulcers, surgical wounds, and chronic wounds. HBS also manufactures veterinary collagen products under the Kollavet™ brand. Beyond branded products, HBS operates a full contract manufacturing division offering private label production, custom formulation, and contract research services (including 510(k) and PMA submissions) for medical-device and consumer-product manufacturers. The company serves hospitals, wound care clinics, healthcare professionals, and veterinary practitioners through a global distribution network and maintains in-house clinical education and regulatory expertise.

Agado Live is a digital health platform designed to support physical and occupational therapists in hospitals and clinics. The platform uses computer vision and AI algorithms to enable therapists to manage multiple patients simultaneously while maintaining individualized care. Core capabilities include video-enabled evaluation with real-time AI assessment of patient conditions, generation of validated personalized treatment plans, ongoing monitoring of functional and cognitive changes, and gamified at-home treatment engagement features. The platform specializes in neurological disorders, with particular focus on Parkinson's disease, multiple sclerosis, and post-stroke rehabilitation. Agado Live enables therapists to split time more effectively between patients without requiring additional staff, thereby increasing clinic capacity and revenues. The platform integrates at-home digital assistance with in-clinic care, allowing treatment plans to be followed both individually and in group settings. Partners include Google, Adventist Healthcare, and international healthcare institutions. The company demonstrates clinical validation through partnerships with established healthcare providers and academic institutions.

Aidar Health designs and develops clinically validated digital medicine software platforms and breath- and saliva-based biosensors for precision disease management across therapeutic areas including respiratory, renal, infectious, cardiovascular, and oncology. The company operates three primary product lines: Aidar Connect (clinician web application for remote patient monitoring and care coordination), MouthLab (medical device for biosensor data collection), and Aidar Care (patient mobile application). Aidar serves multiple market segments through specialized service offerings: Long-Term Care (remote physiological monitoring, chronic care management, transitional care management, hospital-at-home programs); Life Sciences (digital biomarkers, digital companions, decentralized clinical trials, real-world evidence collection); and Population Health Management for payers. The platform enables objective, non-invasive assessment of clinical status, facilitates early disease detection, supports treatment optimization, and enables risk stratification to reduce readmissions and emergency department utilization. Aidar has received FDA clearance for its breath-based medical device and maintains partnerships with major research institutions (NIH, Johns Hopkins, VA) and government agencies (BARDA, NSF). The company targets clinical outcomes improvement and cost reduction through digital-first precision medicine approaches suitable for aging populations and chronic disease management.

InnoVision Medical Technologies provides medical device interoperability software and connectivity solutions that enable seamless integration of medical devices with digital healthcare systems. The company offers embedded software libraries, gateway appliances, and a cloud platform that translate proprietary device data to HL7/FHIR standards-based formats. Their vendor-agnostic solutions support IHE/IEEE-compliant communication, remote device management, and over-the-air updates. IMT serves three customer segments: medical device developers seeking plug-and-play connectivity; healthcare providers requiring real-time device data extraction for EMR integration and visualization; and healthcare IT suppliers needing last-mile connectivity for device data within broader clinical applications. The platform enables device-to-device communication, real-time monitoring, analytics, and clinical decision support without requiring dedicated infrastructure.

EpiWatch is an FDA-cleared, prescription-based mobile health platform that delivers real-time tonic-clonic seizure detection and alerting via Apple Watch and iPhone. The AI-powered application runs passively on wearable devices to monitor seizure activity and provides immediate alerts to caregivers when critical events occur, enabling rapid intervention and reducing the risk of Sudden Unexpected Nocturnal Death in Epilepsy (SUDEP). Designed for both pediatric and adult patients with epilepsy, EpiWatch integrates with family sharing and caregiver contact systems, requiring cellular or Wi-Fi connectivity for continuous monitoring. Available by prescription only in the United States at a monthly subscription fee, the platform empowers patients with independence while providing caregivers actionable intelligence during life-threatening events.

UprightVR Inc. develops an FDA-registered, immersive virtual reality system for balance assessment, rehabilitation, and fall prevention. The platform combines VR technology with neuroscience-based diagnostics to measure sensory-motor integration and vestibular function in 8 minutes, generating detailed clinical and patient reports. Primary markets include physical therapy clinics, senior living communities, rehabilitation hospitals, and medical practices. The system includes RecoVR™ therapeutic rehabilitation modules—gamified exercises designed for patients with concussions, strokes, balance disorders, Parkinson's disease, cerebellar ataxia, hearing and balance impairments, and post-injury recovery. Assessment tools include SafetyNet™ for detecting hidden balance deficits and VOR (vestibular ocular reflex) retraining games. The company emphasizes portable, affordable deployment requiring minimal space and setup. Revenue model targets higher insurance reimbursement rates for advanced balance assessment and therapy. Developed by Geoffrey Wright, Ph.D., Professor of Neuromotor Sciences at Temple University, with two decades of clinical research validation across diverse patient populations. Offers comprehensive customer support including onboarding, remote and on-site training, clinical consultations, and data analytics. Continuous software updates add new assessments and rehabilitation modules.